Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
About TRIUMPH-2, TRIUMPH-3, and the TRIUMPH clinical trial program TRIUMPH-2 (NCT05929079) is a Phase 3, 80-week, randomized, double-blind, and placebo-controlled trial under a basket design investigating the efficacy and safety of retatrutide once weekly compared with placebo in participants with type 2 diabetes and obesity or overweight
However, the mechanism by which GLP-1RAs reduce alcohol intake remains unclear
For an existing comparison based on separate trials, see our retatrutide vs tirzepatide analysis
Eligible Medicare patients may also qualify for FDA-approved GLP-1 medications through the Medicare GLP-1 Bridge Program
But the compounders say patients still face spot shortages at pharmacies, especially for starter doses, and that compounded versions remain far cheaper
US$ 19.98
US$ 22.32
US$ 20.02
US$ 20.40
US$ 29.00
US$ 26.44
US$ 29.11
US$ 25.57
